Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$651M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$622M |
| 3 |
Merck
MRK
|
+$496M |
| 4 |
Adobe
ADBE
|
+$446M |
| 5 |
CRH
CRH
|
+$410M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.33B |
| 2 |
Microsoft
MSFT
|
+$965M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$542M |
| 4 |
NVIDIA
NVDA
|
+$522M |
| 5 |
Linde
LIN
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.03% |
| 2 | Technology | 8.55% |
| 3 | Healthcare | 6.96% |
| 4 | Financials | 6.02% |
| 5 | Industrials | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4451
CALL
GitLab
GTLB
$7.58B
| $712K | ﹤0.01% |
+12,200
| New | +$799K |
|
|
KNTE
4452
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $711K | ﹤0.01% |
267,355
-297,577
| -53% | -$737K |
|
|
ARCH
4453
DELISTED
Arch Resources, Inc.
ARCH
| $711K | ﹤0.01% |
4,420
-91,826
| -95% | -$15.7M |
|
4454
Vanguard Energy ETF
VDE
$10.7B
| $707K | ﹤0.01% |
+5,371
| New | +$644K |
|
4455
Moelis & Co
MC
$5.07B
| $704K | ﹤0.01% |
12,397
-13,276
| -52% | -$725K |
|
4456
PUT
Helen of Troy
HELE
$667M
| $703K | ﹤0.01% |
6,100
-27,200
| -82% | -$3.25M |
|
4457
Bristol-Myers Squibb
BMY
$136B
| $703K | ﹤0.01% |
12,960
-2,474,633
| -99% | -$126M |
|
4458
CALL
Teva Pharmaceuticals
TEVA
$42.5B
| $703K | ﹤0.01% |
49,800
-207,000
| -81% | -$2.61M |
|
|
INVX
4459
Innovex International
INVX
$2.11B
| $701K | ﹤0.01% |
+31,136
| New | +$681K |
|
4460
South Plains Financial
SPFI
$823M
| $700K | ﹤0.01% |
26,177
+19,136
| +272% | +$513K |
|
4461
CALL
Twist Bioscience
TWST
$8.87B
| $700K | ﹤0.01% |
+20,400
| New | +$736K |
|
4462
Nano X Imaging
NNOX
$65.2M
| $696K | ﹤0.01% |
71,236
+55,005
| +339% | +$441K |
|
4463
Vanguard Total International Stock ETF
VXUS
$163B
| $694K | ﹤0.01% |
11,501
-8,281
| -42% | -$482K |
|
|
FNCB
4464
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $693K | ﹤0.01% |
114,183
+97,779
| +596% | +$607K |
|
|
MPT
4465
Medical Properties Trust
MPT
$2.44B
| $693K | ﹤0.01% |
147,449
-6,533,572
| -98% | -$25M |
|
4466
PUT
InterDigital
IDCC
$8.65B
| $692K | ﹤0.01% |
+6,500
| New | +$687K |
|
4467
CALL
Bio-Rad Laboratories Class A
BIO
$10.4B
| $692K | ﹤0.01% |
+2,000
| New | +$658K |
|
|
TWOU
4468
DELISTED
2U Inc
TWOU
| $690K | ﹤0.01% |
59,026
-27,762
| -32% | -$540K |
|
4469
Imperial Oil
IMO
$63.1B
| $687K | ﹤0.01% |
9,932
-531,606
| -98% | -$32.5M |
|
|
NFGC
4470
New Found Gold
NFGC
$734M
| $686K | ﹤0.01% |
185,596
+62,128
| +50% | +$207K |
|
4471
CALL
Teladoc Health
TDOC
$1.18B
| $686K | ﹤0.01% |
+45,400
| New | +$824K |
|
4472
NNN REIT
NNN
$8.77B
| $685K | ﹤0.01% |
16,029
-707,564
| -98% | -$29.4M |
|
4473
Woori Financial
WF
$17.8B
| $685K | ﹤0.01% |
+21,116
| New | +$677K |
|
4474
Cue Biopharma
CUE
$203M
| $684K | ﹤0.01% |
12,070
+2,882
| +31% | +$203K |
|
4475
Acrivon Therapeutics
ACRV
$88.3M
| $683K | ﹤0.01% |
+95,497
| New | +$443K |
|
Similar funds
Israel Englander's Q1 2024 Portfolio in Review
As of Q1 2024, Israel Englander held 6,887 positions worth $234B, up 1.3% from $231B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Israel Englander's Q1 2024 filing shows 858 new, 2,292 increased, 2,484 reduced and 745 closed positions. Its largest new stake was iShares Bitcoin Trust: 20,859,447 shares worth $844M. The largest sale was iShares Core S&P 500 ETF, an estimated $4.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q1 2024 buy was iShares Bitcoin Trust: 20,859,447 shares worth $844M.
- Israel Englander added most to Merck in Q1 2024, an estimated $496M increase.
- Israel Englander's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.33B.
- Israel Englander fully exited Splunk Inc in Q1 2024, selling an estimated $319M.
- Israel Englander's ten largest holdings make up 17% of its $234B portfolio in Q1 2024.
- Israel Englander opened 858 new positions and closed 745 in Q1 2024.
- Israel Englander's portfolio value rose 1.3% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.